The Khanh Hoa-based Institute of Vaccines and Medical Biologicals under the Ministry of Health in coordination with PATH organisation has jointly studied a COVID-19 vaccine called Covicac, which uses egg-based vaccine production technology.
|
Made-in-Vietnam COVID-19 vaccine Covivac is a product by the Institute of Vaccines and Medical Biologicals based in Khanh Hoa Province. (Photo: VNA) |
|
The live NDV-Lasota-S virus is injected into a membrane of fertilised hen’s egg and cultivated, then the propagated viruses are extracted from the membrane to be inactivated while still maintain their physical properties. (Photo: VNA) |
|
Egg candling, a step within Covivac production process, is carried out in a modern vaccine production facility in Cam Lam District, Khanh Hoa Province. (Photo: VNA) |
|
Checking the quality of vaccine Covivac. (Photo: VNA) |
|
The vaccine is produced at a modern vaccine production facility in Cam Lam District, Khanh Hoa Province. (Photo: VNA) |
|
Covivac is produced under egg-based vaccine production technology by a group of researchers from Institute of Vaccines and Medical Biologicals at a vaccine production facility in Cam Lam District, Khanh Hoa Province. (Photo: VNA) |
|
Eggs are carefully selected from a French breed of chicken as they are large, uniform and has a white shell, which make them easy to observe the culture of NDV-Lasota-S virus. (Photo: VNA) |
|
Parent chicken are free from antibiotics and bred in a hygienic environment where diseases are strictly controlled so that they can release high-quality eggs serving the study of Covivac. (Photo: VNA) |
VNP/VNA
The clinical trial of the domestically-made Nanocovax vaccine is going smoothly, and by the end of September, Vietnam will have its first Covid-19 vaccine.
Vietnam will continue to test the domestically-made Covid-19 vaccine called Covivac on 30 volunteers on March 23-25.